Oramed Pharmaceuticals (Israel) Market Value
| ORMP Stock | 8.63 0.02 0.23% |
| Symbol | Oramed |
Oramed Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oramed Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oramed Pharmaceuticals.
| 06/08/2023 |
| 11/29/2024 |
If you would invest 0.00 in Oramed Pharmaceuticals on June 8, 2023 and sell it all today you would earn a total of 0.00 from holding Oramed Pharmaceuticals or generate 0.0% return on investment in Oramed Pharmaceuticals over 540 days. Oramed Pharmaceuticals is related to or competes with YD More, Millennium Food, Azorim Investment, Israel China, Ram On, Adgar Investments, and Netz Hotels. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally in... More
Oramed Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oramed Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oramed Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 14.85 | |||
| Value At Risk | (4.07) | |||
| Potential Upside | 3.23 |
Oramed Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oramed Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oramed Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Oramed Pharmaceuticals historical prices to predict the future Oramed Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | 0.1691 |
Oramed Pharmaceuticals Backtested Returns
Oramed Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0303, which implies the firm had a -0.0303% return per unit of risk over the last 3 months. Oramed Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oramed Pharmaceuticals' Risk Adjusted Performance of (0.03), variance of 7.01, and Coefficient Of Variation of (2,217) to confirm the risk estimate we provide. The company holds a Beta of -0.77, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Oramed Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Oramed Pharmaceuticals is likely to outperform the market. At this point, Oramed Pharmaceuticals has a negative expected return of -0.0574%. Please make sure to check Oramed Pharmaceuticals' standard deviation, jensen alpha, and the relationship between the coefficient of variation and information ratio , to decide if Oramed Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.47 |
Average predictability
Oramed Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Oramed Pharmaceuticals time series from 8th of June 2023 to 4th of March 2024 and 4th of March 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oramed Pharmaceuticals price movement. The serial correlation of 0.47 indicates that about 47.0% of current Oramed Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 126.6 K |
Oramed Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Oramed Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oramed Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Oramed Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Oramed Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oramed Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oramed Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oramed Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oramed Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Oramed Pharmaceuticals Lagged Returns
When evaluating Oramed Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oramed Pharmaceuticals stock have on its future price. Oramed Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oramed Pharmaceuticals autocorrelation shows the relationship between Oramed Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Oramed Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Oramed Stock
When determining whether Oramed Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Oramed Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Oramed Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Oramed Pharmaceuticals Stock:Check out Oramed Pharmaceuticals Correlation, Oramed Pharmaceuticals Volatility and Oramed Pharmaceuticals Alpha and Beta module to complement your research on Oramed Pharmaceuticals. For information on how to trade Oramed Stock refer to our How to Trade Oramed Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Oramed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.